Common TitleELECTRON (Overview): Arms 1-22
Official Title Efficacy of Nucleotide Polymerase Inhibitor sofosbuvir plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside inhibitor GS-9669 Against HCV Genotype 1 Infection.
Phase Phase II
ClinicalTrials.gov NCT01260350
Treatments
Sofosbuvir
Sofosbuvir
Tradename:SovaldiOther Names:SOFClass:FDA-ApprovedFunding
IndustryGilead Sciences